| 发明名称 |
Ankle and foot bone growth compositions and methods |
| 摘要 |
The present invention provides an improved technique for spinal fusion involving the administration of an HMG-CoA reductase inhibitor to a fusion. The HMG-CoA reductase inhibitor is preferably delivered to the site by a carrier. More preferably, the HMG-CoA reductase inhibitor is delivered to the site by a non-compressible delivery vehicle. The invention is suitable for promoting non-anatomic or heterotopic bone growth between any bony surfaces where bone growth is desired but does not naturally occur. |
| 申请公布号 |
US9155629(B2) |
申请公布日期 |
2015.10.13 |
| 申请号 |
US201113306830 |
申请日期 |
2011.11.29 |
| 申请人 |
|
发明人 |
Remington Benjamin J.;Bearss David J.;Shahi Kavian |
| 分类号 |
A61F2/02;A61F2/44;A61L27/56;A61L27/58;A61K9/00;A61K31/22;A61K31/366;A61K31/401;A61L27/54;A61F2/28;A61F2/30 |
主分类号 |
A61F2/02 |
| 代理机构 |
Haverstock & Owens LLP |
代理人 |
Haverstock & Owens LLP |
| 主权项 |
1. A method for enhancing non-anatomic bone formation of a foot or ankle bone, the method comprising the steps of administering an HMG-CoA reductase inhibitor to the foot or ankle bone. |
| 地址 |
|
